Spots Global Cancer Trial Database for tisotumab vedotin
Every month we try and update this database with for tisotumab vedotin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) | NCT03657043 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | tisotumab vedot... | 18 Years - | Seagen Inc. | |
| A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies | NCT03913741 | Solid Tumor | tisotumab vedot... | 20 Years - | Genmab | |
| A Trial of Tisotumab Vedotin in Cervical Cancer | NCT03438396 | Cervical Cancer | tisotumab vedot... | 18 Years - | Seagen Inc. | |
| Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors | NCT03485209 | Colorectal Neop... Carcinoma, Non-... Exocrine Pancre... Carcinoma, Squa... | tisotumab vedot... pembrolizumab carboplatin cisplatin | 18 Years - | Seagen Inc. | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) | NCT03657043 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | tisotumab vedot... | 18 Years - | Seagen Inc. | |
| To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies | NCT05866354 | Solid Malignanc... | Tisotumab Vedot... | 18 Years - | Zai Lab (Hong Kong), Ltd. | |
| To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies | NCT05866354 | Solid Malignanc... | Tisotumab Vedot... | 18 Years - | Zai Lab (Hong Kong), Ltd. | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| A Trial of Tisotumab Vedotin in Cervical Cancer | NCT03438396 | Cervical Cancer | tisotumab vedot... | 18 Years - | Seagen Inc. | |
| Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | NCT04697628 | Cervical Cancer | tisotumab vedot... topotecan vinorelbine gemcitabine irinotecan pemetrexed | 18 Years - | Seagen Inc. | |
| Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer | NCT03786081 | Cervical Cancer | Tisotumab Vedot... Bevacizumab Pembrolizumab Carboplatin | 18 Years - | Seagen Inc. | |
| Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer | NCT03786081 | Cervical Cancer | Tisotumab Vedot... Bevacizumab Pembrolizumab Carboplatin | 18 Years - | Seagen Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
